Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Surgery Per Diem 87384BR Job Summary This is a training position. The Trainee will be enrolled in a state-approved training program for the Clinical Histocompatibility Scientist (CHS). (https
-
of neutralising antibody responses following infection or vaccination; (iii) a proven track record of impactful research, publications, external grants and leadership; (iv) experience in teaching and postgraduate
-
antibodies to support our own work as well as other researchers worldwide. Overall, the work of the lab is aimed to determine how anti-tumor immune responses can be harnessed for improved therapy outcomes
-
, causal inference, and machine learning to study real-world treatment patterns, effectiveness, and safety of monoclonal antibodies (mAbs) used in autoimmune, inflammatory, and neurological diseases. Using
-
Cryopreserve cells Prepare flow cytometry samples, acquire data, analyze and summarize results Perform antibody titration Conduct PCR and other molecular biology assays Execute in vitro immunological assays
-
with established safety procedures and maintains required documentation on laboratory and specimen conditions (maintaining lab freezer maps and plasmid and antibody maps and reagent storage with
-
of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics for the treatment of cancer and autoimmunity. This research has led
-
Science About the project This PhD project integrates pharmacoepidemiology, causal inference, and machine learning to study real-world treatment patterns, effectiveness, and safety of monoclonal antibodies
-
• Experience in cell cultures. • Experience with cell labeling techniques using antibodies, ELISA, immunofluorescence, multiplex assays, and immunohistochemistry. • Experience with spectral cytometry, including
-
susceptibility to both nicotine addiction and lung cancer. We will develop specific and accurate camelid antibodies fragments (nanobodies) to examine the distribution of WT and mutant receptor in native conditions